Home › Funds › Orion Investment Co › IOVA
Orion Investment Co position in IOVA
Iovance Biotherapeutics Inc · Health Care
Orion Investment Co reported holding 2,083,377 shares of IOVA (Iovance Biotherapeutics Inc) in its Q3 2026 13F filing — a position valued at US$30.9M, representing 8.19% of its reported portfolio and ranking #2 among its reported holdings. Orion Investment Co has disclosed IOVA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-11 · Source: SEC EDGAR Form 13F-HR
How Orion Investment Co's IOVA position evolved
Orion Investment Co first disclosed a stake in IOVA in Q2 2024 at 794,700 shares (US$6.4M). The position peaked in Q3 2026 at 2,083,377 shares, worth US$30.9M. Across 10 filings, Orion Investment Co increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 2,083,377 shares valued at US$30.9M. Notable position changes include a 99% increase in Q2 2025 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 794.70K | $6.37M | New |
| Q3 2024 | 906.28K | $8.51M | Add |
| Q4 2024 | 1.06M | $7.85M | Add |
| Q1 2025 | 1.18M | $3.92M | Add |
| Q2 2025 | 2.34M | $4.02M | Add |
| Q3 2025 | 1.85M | $4.02M | Reduce |
| Q4 2025 | 1.86M | $5.07M | Hold |
| Q1 2026 | 2.07M | $7.25M | Add |
| Q2 2026 | 2.07M | $8.62M | Hold |
| Q3 2026 | 2.08M | $30.88M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IOVA and 13F data
IOVA (Iovance Biotherapeutics Inc) is a Health Care company. 28 other funds we track also report a position in IOVA — the largest reported positions include MHR FUND MANAGEMENT LLC (US$120.5M), Palo Alto Investors LP (US$22.0M), Mirador Capital Partners LP (US$16.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IOVA
- MHR FUND MANAGEMENT LLC 28.97M sh · $120.50M · Q2 2026
- Palo Alto Investors LP 5.30M sh · $22.03M · Q2 2026
- Mirador Capital Partners LP 1.10M sh · $16.24M · Q3 2026
More on Orion Investment Co
FAQ
How long has Orion Investment Co held IOVA?
Orion Investment Co has disclosed IOVA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Orion Investment Co's current position in IOVA?
As of Q3 2026, Orion Investment Co holds 2.08M shares of IOVA (Iovance Biotherapeutics Inc), valued at $30.88M, representing 8.19% of its reported portfolio and ranking #2.
Has Orion Investment Co been buying or selling IOVA?
In the latest 13F filing (Q3 2026), Orion Investment Co held unchanged its position in IOVA. The position peaked in Q3 2026 at 2.08M shares.
Which other funds hold IOVA?
Other major institutional holders of IOVA include MHR FUND MANAGEMENT LLC, Palo Alto Investors LP, Mirador Capital Partners LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.